Relationship between group-specific component protein and the development of asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 5, 2011, Pages 528-536

  Lee, Shin Hwa ^a   Kim, Kyung Hun ^a   Kim, Jin Moo ^a   Yoon, Sang Hyuk ^a   Kim, Tae Hoon ^a   Park, Sung Woo ^a   Park, Jong Sook ^a   Uh, Soo Taek ^b   Lee, Ho Sung ^b   Kim, Yong Hoon ^b   Kang, Jin Hyun ^c   Chung, Il Yup ^c   Paik, Young Ki ^d   Rhim, Taiyoun ^e   Park, Choon Sik ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Hanyang University   (South Korea)

^d Yonsei University   (South Korea)

^e Hanyang University   (South Korea)

Author keywords

2D electrophoresis; Asthma; BAL; Gc; Proteomics; Therapeutics

Indexed keywords

ASTHMA SPECIFIC PROTEIN; EOTAXIN; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; HAPTOGLOBIN; HEMOPEXIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; NEUTRALIZING ANTIBODY; OVALBUMIN; PLASMA PROTEIN; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GOBLET CELL; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; STATISTICAL SIGNIFICANCE; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ADULT; ANIMALS; ASTHMA; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE TRANSFERASE; HUMANS; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEINS; RNA, MESSENGER; TANDEM MASS SPECTROMETRY;

EID: 80052464259     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201006-0951OC     Document Type: Article

References (48)

1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, et al. Global strategy for asthma management and prevention: Gina executive summary. Eur Respir J 2008;31:143-178.
2. Busse WW, Banks-Schlegel S, Wenzel SE. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000;106:1033-1042. (Pubitemid 32006254)
3. Holgate ST. A brief history of asthma and its mechanisms to modern concepts of disease pathogenesis. Allergy Asthma Immunol Res 2010;2:165-171.
4. Jeffery P. Structural alterations and inflammation of bronchi in asthma. Int J Clin Pract Suppl 1998;96:5-14.
5. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004;22:789-815. (Pubitemid 38680442)
6. Sengler C, Lau S, Wahn U, Nickel R. Interactions between genes and environmental factors in asthma and atopy: new developments. Respir Res 2002;3:7.
7. Kavuru MS, Dweik RA, Thomassen MJ. Role of bronchoscopy in asthma research. Clin Chest Med 1999;20:153-189. (Pubitemid 29161858)
8. Bowler RP, Duda B, Chan ED, Enghild JJ, Ware LB, Matthay MA, Duncan MW. Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004;286:L1095-L1104. (Pubitemid 38656643)
9. Plymoth A, Lofdahl CG, Ekberg-Jansson A, Dahlback M, Lindberg H, Fehniger TE, Marko-Varga G. Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics 2003;3:962-972. (Pubitemid 36801684)
10. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-362. (Pubitemid 32107645)
11. Candiano G, Bruschi M, Pedemonte N, Caci E, Liberatori S, Bini L, Pellegrini C, Vigano M, O'Connor BJ, Lee TH, et al. Gelsolin secretion in interleukin-4-treated bronchial epithelia and in asthmatic airways. Am J Respir Crit Care Med 2005;172:1090-1096. (Pubitemid 43066643)
12. Lindahl M, Stahlbom B, Tagesson C. Newly identified proteins in human nasal and bronchoalveolar lavage fluids: potential biomedical and clinical applications. Electrophoresis 1999;20:3670-3676. (Pubitemid 30007265)
13. Wu J, Kobayashi M, Sousa EA, Liu W, Cai J, Goldman SJ, Dorner AJ, Projan SJ, Kavuru MS, Qiu Y, et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics 2005;4:1251-1264. (Pubitemid 41448713)
14. Kim TH, Lee YH, Kim KH, Lee SH, Cha JY, Shin EK, Jung S, Jang AS, Park SW, Uh ST, et al. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Am J Respir Crit Care Med 2010;182:633-642.
15. Daiger SP, Schanfield MS, Cavalli-Sforza LL. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 1975;72:2076-2080.
16. Gomme PT, Bertolini J. Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 2004;22:340-345. (Pubitemid 38887542)
17. Kew RR, Fisher JA, Webster RO. Co-chemotactic effect of Gc-globulin (vitamin D binding protein) for c5a: transient conversion into an active co-chemotaxin by neutrophils. J Immunol 1995;155:5369-5374.
18. DiMartino SJ, Kew RR. Initial characterization of the vitamin D binding protein (Gc-globulin) binding site on the neutrophil plasma membrane: evidence for a chondroitin sulfate proteoglycan. J Immunol 1999;163:2135-2142. (Pubitemid 29382220)
19. Gumireddy K, Reddy CD, Swamy N. Mitogen-activated protein kinase pathway mediates dbp-maf-induced apoptosis in raw 264.7 macrophages. J Cell Biochem 2003;90:87-96. (Pubitemid 37052312)
20. Jeong H, Rhim T, Ahn MH, Yoon PO, Kim SH, Chung IY, Uh S, Kim SI, Park CS. Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma. J Korean Med Sci 2005;20:579-585. (Pubitemid 41265134)
21. Metcalf JP, Thompson AB, Gossman GL, Nelson KJ, Koyama S, Rennard SI, Robbins RA. Gc globulin functions as a cochemotaxin in the lower respiratory tract: a potential mechanism for lung neutrophil recruitment in cigarette smokers. Am Rev Respir Dis 1991;143:844-849.
22. Robbins RA, Gossman GL, Nelson KJ, Koyama S, Thompson AB, Rennard SI. Inactivation of chemotactic factor inactivator by cigarette smoke: a potential mechanism of modulating neutrophil recruitment to the lung. Am Rev Respir Dis 1990;142:763-768. (Pubitemid 20344641)
23. Park BL, Kim LH, Choi YH, Lee JH, Rhim T, Lee YM, Uh ST, Park HS, Choi BW, Hong SJ, et al. Interleukin 3 (IL3) polymorphisms associated with decreased risk of asthma and atopy. J Hum Genet 2004;49:517-527. (Pubitemid 39506535)
24. Park CS, Lee SM, Uh ST, Kim HT, Chung YT, Kim YH, Choi BW, Hue SH, Lee HB. Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma. J Allergy Clin Immunol 1993;91:623-633.
25. Cha MH, Rhim T, Kim KH, Jang AS, Paik YK, Park CS. Proteomic identification of macrophage migration-inhibitory factor upon exposure to TiO2 particles. Mol Cell Proteomics 2007;6:56-63. (Pubitemid 46152691)
26. Choi JM, Ahn MH, Chae WJ, Jung YG, Park JC, Song HM, Kim YE, Shin JA, Park CS, Park JW, et al. Intranasal delivery of the cytoplasmic domain of ctla-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med 2006;12:574-579.
27. Kayanoki Y, Fujii J, Islam KN, Suzuki K, Kawata S, Matsuzawa Y, Taniguchi N. The protective role of glutathione peroxidase in apoptosis induced by reactive oxygen species. J Biochem 1996;119: 817-822. (Pubitemid 26131786)
28. Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987;917:219-223. (Pubitemid 17004970)
29. Sabounchi-Schutt F, Astrom J, Hellman U, Eklund A, Grunewald J. Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach. Eur Respir J 2003;21:414-420. (Pubitemid 36336198)
30. Wattiez R, Hermans C, Cruyt C, Bernard A, Falmagne P. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 2000;21:2703-2712.
31. Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006;533:222-239. (Pubitemid 43340015)
32. Owen S, Pearson D, Suarez-Mendez V, O'Driscoll R, Woodcock A. Evidence of free-radical activity in asthma. N Engl J Med 1991;325: 586-587.
33. Tang LF, Du LZ, Chen ZM, Zou CC. Levels of matrix metalloproteinase- 9 and its inhibitor in bronchoalveolar lavage cells of asthmatic children. Fetal Pediatr Pathol 2006;25:1-7.
34. Dobryszycka W. Biological functions of haptoglobin-new pieces to an old puzzle. Eur J Clin Chem Clin Biochem 1997;35:647-654. (Pubitemid 27453361)
35. Yang F, Ghio AJ, Herbert DC, Weaker FJ, Walter CA, Coalson JJ. Pulmonary expression of the human haptoglobin gene. Am J Respir Cell Mol Biol 2000;23:277-282.
36. Kauffmann F, Frette C, Annesi I, Oryszczyn MP, Dore MF, Neukirch F. Relationships of haptoglobin level to FEV1, wheezing, bronchial hyper-responsiveness and allergy. Clin Exp Allergy 1991;21:669-674.
37. Koh YY, Kim YW, Park JD, Oh JW. A comparison of serum haptoglobin levels between acute exacerbation and clinical remission in asthma. Clin Exp Allergy 1996;26:1202-1209. (Pubitemid 26354371)
38. White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000;11:320-327.
39. Krug N, Tschernig T, Erpenbeck VJ, Hohlfeld JM, Kohl J. Complement factors c3a and c5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 2001;164:1841-1843. (Pubitemid 33152317)
40. Humbles AA, Lu B, Nilsson CA, Lilly C, Israel E, Fujiwara Y, Gerard NP, Gerard C. A role for the c3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000;406:998-1001.
41. Wills-Karp M. Complement activation pathways: A bridge between innate and adaptive immune responses in asthma. Proc Am Thorac Soc 2007;4:247-251. (Pubitemid 47036443)
42. Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ. 1alpha,25-dihydroxyvitamin d3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol 2008;180:5211-5221.
43. Ito I, Nagai S, Hoshino Y,Muro S, Hirai T, Tsukino M,Mishima M. Risk and severity of COPD is associated with the group-specific component of serum globulin 1f allele. Chest 2004;125:63-70. (Pubitemid 38114565)
44. Laufs J, Andrason H, Sigvaldason A, Halapi E, Thorsteinsson L, Jonasson K, Soebech E, Gislason T, Gulcher JR, Stefansson K, et al. Association of vitamin d binding protein variants with chronic mucus hypersecretion in Iceland. Am J Pharmacogenomics 2004;4:63-68. (Pubitemid 38325706)
45. Ezura Y, Nakajima T, Kajita M, Ishida R, Inoue S, Yoshida H, Suzuki T, Shiraki M, Hosoi T, Orimo H, et al. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res 2003;18:1642-1649. (Pubitemid 37022922)
46. Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006;372:33-42. (Pubitemid 44286753)
47. Schellenberg D, Pare PD, Weir TD, Spinelli JJ, Walker BA, Sandford AJ. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998;157:957-961.
48. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-867.